Workflow
通化东宝药业股份有限公司关于控股股东股份解押及再质押公告

Core Viewpoint - The announcement details the share pledge and unpledging activities of Tonghua Dongbao Pharmaceutical Co., Ltd.'s controlling shareholder, Dongbao Industrial Group Co., Ltd., indicating a high level of share pledging and its implications for the company's financial health and governance [1][2][3]. Group 1: Shareholding and Pledge Details - Dongbao Group and its concerted parties hold a total of 634,511,775 shares, accounting for 32.40% of the company's total shares [1]. - After the recent unpledging and re-pledging, the total number of pledged shares is 565,939,472, which represents 89.19% of the shares held by Dongbao Group and its concerted parties, and 28.90% of the company's total shares [1][2]. - Dongbao Group holds 612,649,596 shares, which is 31.28% of the total shares, with 565,939,472 shares pledged, equating to 92.38% of its holdings [1][2]. Group 2: Financial Implications and Debt Management - On September 22, 2025, Dongbao Group unpledged 14,000,000 shares and subsequently pledged the same number of shares to China Construction Bank for debt repayment purposes [2][3]. - The total number of shares due for pledge expiration in the next six months is 81,000,000, representing 13.22% of its holdings and 4.14% of the company's total shares, with a corresponding financing balance of 31.5 million [3]. - For the next year, 191,350,000 shares are set to expire, which is 31.23% of its holdings and 9.77% of the company's total shares, with a financing balance of 96.5 million [3]. Group 3: Impact on Company Operations and Governance - The share pledging activities are not expected to impact the company's operations or governance, nor will they lead to a change in actual control [3][4]. - Dongbao Group has no performance compensation obligations that could be affected by the share pledging [3][4]. Group 4: Financial Health and Risk Assessment - Dongbao Group's financial health shows a relatively high debt-to-asset ratio and low liquidity ratios, which may pose challenges for debt repayment [9]. - The group plans to enhance operational efficiency, accelerate the conversion of research results, and manage share pledging ratios to mitigate risks associated with high share pledging [9][10].